GE Healthcare Technologies Inc
GEHCToday
+7.14%
5 Days
+8.55%
1 Month
+14.41%
6 Months
+8.22%
Year to Date
-6.92%
1 Year
-2.56%
Key Figures
• GE HealthCare reported Q3 results exceeding expectations and raised full-year guidance. • Total backlog reached record levels with significant revenue visibility and margin expansion. • Technical indicators show a MACD buy signal and an overbought RSI condition.
• CVS stock rose due to strong earnings outlook and favorable regulation. • Medicare Advantage payment rates increase benefits CVS's Aetna unit. • Analyst ratings and bullish options trading signal investor confidence.
• Medtronic's share price declined due to negative analyst sentiment. • Cybersecurity incident disclosure contributed to investor concerns and uncertainty. • Stock reached a 52-week low, signaling lack of investor confidence.
• Product safety concerns and regulatory scrutiny impact share price. • Challenges in China and Japan markets affect international growth. • Institutional investors reduced stakes, contributing to price decline.
GE Healthcare Technologies Inc's Score
Media Coverage
Analyst Rating
GE Healthcare Technologies Inc Technical Analysis
Financial Indicators
Earnings
GE Healthcare Technologies Inc Profile
Ownership
| Shareholders | Proportion |
|---|---|
| Dodge & Cox | 6.86% |
| Vanguard Capital Management, LLC | 6.35% |
| Capital Research Global Investors | 5.58% |
| BlackRock Institutional Trust Company, N.A. | 5.48% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 49.87% |
| Investment Advisor/Hedge Fund | 30.52% |
| Research Firm | 2.97% |
| Hedge Fund | 2.93% |
Related Instruments
